QuinStreet: Lake Street lowers PT to $18 from $19, maintains Hold rating.

QuinStreet: Lake Street lowers PT to $18 from $19, maintains Hold rating.

Lake Street Capital Markets has revised its price target for Sight Sciences Inc. (NASDAQ:SGHT) from $19 to $18, while maintaining its Hold rating. The adjustment comes following the company's second-quarter 2025 financial results, which exceeded market expectations.

Sight Sciences reported $19.6 million in revenue for the quarter, surpassing the forecasted $18.18 million. The company also posted a narrower-than-expected loss per share of $0.23, compared to the anticipated loss of $0.26. These results marked a positive earnings surprise for Sight Sciences.

The stock experienced a decline in after-hours trading, aligning with broader market trends. Despite the strong financial performance, the company's stock has shown resilience, gaining over 8.5% in the past week and trading at $4.13, according to InvestingPro data.

Lake Street cited several factors supporting the company's strong performance, including stabilization in its Surgical glaucoma business, prudently set guidance, improved gross margins, and potential catalysts from Dry eye contract wins. The investment firm noted that Sight Sciences shares currently offer "an attractive risk/reward" ratio, trading at approximately 1.7 times the expected 2025 enterprise value to sales.

Sight Sciences specializes in medical devices for ophthalmology, with products targeting glaucoma and dry eye disease treatment. The company maintains a strong financial position with a current ratio of 10.47, indicating robust liquidity, and holds more cash than debt on its balance sheet.

References:
[1] https://uk.investing.com/news/analyst-ratings/sight-sciences-stock-rating-upgraded-by-lake-street-on-stabilizing-business-93CH-4211167